Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations and their use in the treatment of neurological diseases

Formulations and their use in the treatment of neurological diseases

US Patent 5580580 · Granted Dec 3, 1996

Estimated economic value: $9,486,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Apelin receptor agonists and methods of use2024
Methods of treating kidney failure, and/or improving or stablizing renal functio2024
Treatment of fibrosis, cardiovascular disease and heart failure with modified re2024
Apelin receptor agonists and methods of use2022
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmace2022
Method of treating cardiovascular disease and heart failure with modified relaxi2021
Heteroarylhydroxypyrimidinones as agonists of the APJ receptor2020
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists2020
2,4-dihydroxy-nicotinamides as APJ agonists2019
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses the2019
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists2018
4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists2018